Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00MFY
|
||||
| Former ID |
DIB006771
|
||||
| Drug Name |
GPI-3000
|
||||
| Synonyms |
NPC-17742
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Terminated | [1] | ||
| Company |
Scios Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H22NO5P
|
||||
| Canonical SMILES |
P(=O)(CC[C@H]1[C@@H](C[C@H](C(=O)O)N)CCCC1)(O)O
|
||||
| CAS Number |
CAS 144301-37-1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001817) | ||||
| REF 2 | Treatment with the competitive NMDA antagonist GPI 3000 does not improve outcome after cardiac arrest in dogs. Stroke. 1998 Apr;29(4):824-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.